Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 224

Results For "IMA"

3215 News Found

GenNext Technologies introduces protein footprinting products to Japan through Kiko Tech
Medical Device | May 12, 2022

GenNext Technologies introduces protein footprinting products to Japan through Kiko Tech

GenNext and Kiko Tech will provide sales and marketing, customer service, technical support, training, and related logistical efforts for Flash Oxidation Protein Footprinting Systems.


OvaCis rapid test to detect ovarian cancer gets CE mark
Drug Approval | May 12, 2022

OvaCis rapid test to detect ovarian cancer gets CE mark

Revolutionary ovarian cancer rapid test available Q4 2022


USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19
Drug Approval | May 12, 2022

USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19

Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19


Philips expands manufacturing and research facility in Pune, Maharashtra
News | May 12, 2022

Philips expands manufacturing and research facility in Pune, Maharashtra

The company exports mobile surgery equipment to over 100 countries from Pune


Suven Pharmaceuticals - CDMO core growth intact; formulations to pick up
News | May 12, 2022

Suven Pharmaceuticals - CDMO core growth intact; formulations to pick up

Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins


Ajanta Pharma - Stellar show in its branded generics: Anand Rathi
News | May 12, 2022

Ajanta Pharma - Stellar show in its branded generics: Anand Rathi

With launches, continuing momentum in India, other branded markets and a pick-up in the US, Ajanta would deliver 12% revenue/PAT growth each over FY22-24


Ascletis announces U.S. IND approval of ASC22 for HIV patients
Biotech | May 11, 2022

Ascletis announces U.S. IND approval of ASC22 for HIV patients

ASC22 (Envafolimab) is a subcutaneously administered single-domain antibody against PD-L1 and has the potential to restore virus-specific immune responses in patients with chronic viral infection


Alembic Pharmaceuticals receives USFDA  approval for Arformoterol Tartrate
Drug Approval | May 11, 2022

Alembic Pharmaceuticals receives USFDA approval for Arformoterol Tartrate

This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies


Hetero unveils new logo and corporate brand identity
News | May 11, 2022

Hetero unveils new logo and corporate brand identity

The new logo is a refreshing change from the version that has served Hetero well for three decades. And yet its reflection can be seen in the new version


Bayer posts higher sales, profit in first quarter
News | May 11, 2022

Bayer posts higher sales, profit in first quarter

Company's net income rose by 57.5 percent to 3.291 billion euros in Q1